CAD 1.75
(-2.23%)
Year | Eps | Eps Growth |
---|---|---|
2023 | -0.37 CAD | -1648.12% |
2022 | 0.02 CAD | 105.69% |
2021 | -0.42 CAD | -20.0% |
2020 | -0.35 CAD | -34.62% |
2019 | -0.26 CAD | -44.44% |
2018 | -0.18 CAD | 41.94% |
2017 | -0.31 CAD | 31.11% |
2016 | -0.45 CAD | -439.57% |
2015 | -0.08 CAD | -56.18% |
2014 | -0.05 CAD | -8.76% |
2013 | -0.05 CAD | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q1 | -0.05 CAD | 75.3% |
2023 FY | - CAD | -1648.12% |
2023 Q3 | -0.07 CAD | -33.64% |
2023 Q1 | -0.04 CAD | 25.81% |
2023 Q2 | -0.05 CAD | -30.17% |
2023 Q4 | -0.20 CAD | -179.72% |
2022 Q2 | -0.01 CAD | 80.95% |
2022 Q4 | -0.06 CAD | -237.8% |
2022 Q3 | -0.02 CAD | -16.31% |
2022 Q1 | -0.07 CAD | -28.25% |
2022 FY | - CAD | 105.69% |
2021 Q4 | -0.06 CAD | 35.17% |
2021 FY | - CAD | -20.0% |
2021 Q1 | -0.12 CAD | 0.0% |
2021 Q2 | -0.15 CAD | -25.0% |
2021 Q3 | -0.09 CAD | 40.67% |
2020 Q1 | -0.05 CAD | 11.64% |
2020 FY | - CAD | -34.62% |
2020 Q2 | -0.08 CAD | -59.47% |
2020 Q4 | -0.12 CAD | -9.09% |
2020 Q3 | -0.11 CAD | -41.94% |
2019 Q4 | -0.06 CAD | 23.61% |
2019 Q3 | -0.07 CAD | -8.93% |
2019 Q2 | -0.07 CAD | -46.24% |
2019 Q1 | -0.05 CAD | -10.51% |
2019 FY | - CAD | -44.44% |
2018 FY | - CAD | 41.94% |
2018 Q4 | -0.04 CAD | 40.64% |
2018 Q3 | -0.07 CAD | -88.77% |
2018 Q2 | -0.04 CAD | 13.51% |
2018 Q1 | -0.04 CAD | 21.27% |
2017 Q1 | -0.09 CAD | -4.04% |
2017 Q4 | -0.05 CAD | 40.18% |
2017 FY | - CAD | 31.11% |
2017 Q2 | -0.07 CAD | 23.92% |
2017 Q3 | -0.09 CAD | -26.91% |
2016 Q1 | -0.03 CAD | 31.65% |
2016 FY | - CAD | -439.57% |
2016 Q3 | -1.88 CAD | -3874.63% |
2016 Q4 | -0.09 CAD | 95.26% |
2016 Q2 | -0.05 CAD | -58.72% |
2015 Q2 | -0.47 CAD | -3305.8% |
2015 Q4 | -0.04 CAD | -24.93% |
2015 Q3 | -0.03 CAD | 92.57% |
2015 FY | - CAD | -56.18% |
2015 Q1 | -0.01 CAD | 0.0% |
2014 FY | - CAD | -8.76% |
2013 FY | - CAD | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
Appili Therapeutics Inc. | -0.03 CAD | -1085.897% |
Eupraxia Pharmaceuticals Inc. | -1.58 CAD | 76.582% |
Helix BioPharma Corp. | -0.21 CAD | -76.19% |
Microbix Biosystems Inc. | -0.00 CAD | -123233.333% |
Satellos Bioscience Inc. | -0.18 CAD | -105.556% |
Oncolytics Biotech Inc. | -0.41 CAD | 9.756% |
Sernova Corp. | -0.13 CAD | -184.615% |